echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Guangzhou Nansha Biopharmaceutical Industrial Park to promote the development of biotechnology industry agglomeration

    Guangzhou Nansha Biopharmaceutical Industrial Park to promote the development of biotechnology industry agglomeration

    • Last Update: 2022-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The reporter learned from the Nansha District Government of Guangzhou City on the 17th that the Hengli Biomedical Industrial Park project of Nansha Science and Technology Innovation Center has officially kicked off the construction
    .
    The project will build a general science and technology park in the field of biotechnology, which will help Nansha District focus on global innovation resources and high-end elements, and promote the agglomeration and development of the biotechnology industry
    .
    According to the Nansha District Government, the project is located in Nansha Biological Valley, Guangzhou, with a construction land of about 49,000 square meters and a total construction area of ​​about 200,000 square meters.
    Excellent enterprises in the fields of therapeutic drugs and new preparations
    .
    It is understood that the Hengli Biopharmaceutical Industrial Park project of Nansha Science and Technology Innovation Center is a key project in Guangzhou and Nansha District.
    Divide the assignment project
    .
    The relevant person in charge of the Nansha District Government said that the project acquired land on February 7 and started construction on the 16th, realizing the model of "getting land and starting construction" and running out of the "Nansha Speed"
    .
    The first phase of the project is planned to be completed and put into operation in the first quarter of 2023, and will realize the construction of "customized" workshops for the first batch of Guangzhou Jiyin Co.
    ,
    Ltd.
    Zheng Kang, Secretary of the Party Group of Nansha District Bureau of Commerce, introduced that in recent years, Nansha has made an all-round layout of the biotechnology industry chain to create a new highland for medical and health care in the Guangdong-Hong Kong-Macao Greater Bay Area
    .
    After several years of hard work, it has shown a good development trend
    .
    At present, the construction of various entrepreneurial platform carriers has been accelerated, innovative projects have been accelerated, and high-end industrial talents have been continuously gathered, and more than 300 enterprises in related industries have been settled in succession
    .
    Huang Min, deputy general manager of Nansha Development and Construction Group, said that after the completion of the project, it will have a linkage effect on the industrial area in the region and become an important node for the exchange of life science and technology between the Guangdong-Hong Kong-Macao Greater Bay Area and the international community
    .
    (over)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.